|
Re: What is measurement date for 5 yr mark?
I am hopeful that with Herceptin use for early stagers, really only within the last 8 years or so, future studies will prove that even we triple+s will have a lower risk of recurrence as well.
I remember my onc. telling me in January 2007, when I started Herceptin, that I was basically a "pioneer", that I would be in the 10 year statistics 10 years hence (now going on 8 years). More so because I am triple +, and very highly ER/PR+. Of the 6 or so triple+ gals I know who started treatment around the same time as I did, all early stagers 1-3, no one has recurred. Hip hip hooray!!
all the best
caya
__________________
ER90%+/PR 50%+/HER 2+
1.7 cm and 1.0 cm.
Stage 1, grade 2, Node Negative (16 nodes tested)
MRM Dec.18/06
3 x FEC, 3 x Taxotere
Herceptin - every 3 weeks for a year, finished May 8/08
Tamoxifen - 2 1/2 years
Femara - Jan. 1, 2010 - July 18, 2012
BRCA1/BRCA2 Negative
Dignosed 10/16/06, age 48 , premenopausal
Mild lymphedema diagnosed June 2009 - breast surgeon and lymph. therapist think it's completely reversible - hope so.
Reclast infusion January 2012
Oopherectomy October 2013
15 Years NED!!
|
Hybrid Mode
